Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Go back to Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update| (NASDAQ: VRDN) | Delayed: 16.63 -0.08 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.71 | 52 Week High | $ | |||
| Open | $17.15 | 52 Week Low | $ | |||
| Day High | $17.44 | P/E | N/A | |||
| Day Low | $16.46 | EPS | $ | |||
| Volume | 4,032,029 | |||||

